The role of lymphatic clearance in brain TB

淋巴清除在脑结核中的作用

基本信息

  • 批准号:
    10522419
  • 负责人:
  • 金额:
    $ 40.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-15 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Brain tuberculosis (TB), the most severe form of tuberculosis, is associated with a complex inflammatory response, tissue damage and cerebral edema. Typically, management of fluid, waste, and immune- surveillance in the periphery is performed by tissue infiltrating lymphoid vessels. While the brain parenchyma does not have lymphoid vessels, recent research has identified that brain fluids (cerebrospinal fluid and interstitial fluid) are collected by meningeal and cribriform lymphoid vessels surrounding the brain, which are crucial for waste clearance and tissue homeostasis in the CNS. It has been shown that inhibition of lymphatic transport accelerates disease pathology and cognitive decline in Alzheimer’s disease, traumatic brain injury, and Parkinson’s disease, but little is known about the potential modulatory role of lymphoid vessels in CNS tuberculosis. Recently we reported that autoimmune inflammation induces lymphangiogenesis at the cribriform plate through the production of VEGFC from inflammatory dendritic cells. Functionally, the induction of new lymphoid vessels upregulates immunoregulatory molecules, and blocking new lymphoid vessel formation has consequences in regulating the severity of the autoimmune disease. In this proposal, we will test how CNS tuberculosis affects meningeal and cribriform lymphoid vessels formation and consequently, their fluid and cell draining function (Aim 1) To understand the impacts on immune-surveillance, we will study how CNS mycobacterial tuberculosis (Mtb) infection alters the expression of immune regulatory molecules on draining lymphoid vessels and how these lymphoid vessels modify brain-derived dendritic cells and their ability to influence downstream T cell priming in the lymph node (Aim 2). Lastly, we will use agents that block or promote lymphangiogenesis to test how brain inflammation, bacterial load, dissemination, and anti-bacterial immunity are affected by alterations of brain drainage with the hope of decreasing CNSTB associated pathologies (Aim 3). CNS tuberculosis is one of the most common bacterial infections of the brain with high mortality with a pressing need for new therapies, and these studies will lead to novel therapeutic strategies in CNSTB. The objectives of this proposal are (1) to test whether infiltrating or resident immune cells produce VEGFC that contributes to cribriform plate-associated, dorsal meningeal, or basal meningeal lymphangiogenesis during central nervous system tuberculosis (CNSTB) (Aim 1); to define cellular and bacterial interaction between Mtb- infected dendritic cells, Mtb, and lymphoid endothelial cells (LECs) (Aim 2); and to understand the translational value of lymphangiogenesis regulators on CNSTB pathogenesis, bacterial control, anti-bacterial responses, and bacterial dissemination (Aim 3). These studies will lead to a new aspect of brain TB pathology and reveal novel information comparing lymphatic vessel responses and brain drainage in different brain inflammations. These studies' long- term objective is to define how the lymphatic system represents a novel target in combating CNSTB.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matyas Sandor其他文献

Matyas Sandor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matyas Sandor', 18)}}的其他基金

The role of lymphatic clearance in brain TB
淋巴清除在脑结核中的作用
  • 批准号:
    10617380
  • 财政年份:
    2022
  • 资助金额:
    $ 40.69万
  • 项目类别:
Human Brain Organoid: a new CNSTB model
人脑类器官:一种新的 CNSTB 模型
  • 批准号:
    10453987
  • 财政年份:
    2021
  • 资助金额:
    $ 40.69万
  • 项目类别:
Innate immunity of granulomatous inflammation: the role of VEGF
肉芽肿性炎症的先天免疫:VEGF 的作用
  • 批准号:
    9238504
  • 财政年份:
    2016
  • 资助金额:
    $ 40.69万
  • 项目类别:
Innate immunity of granulomatous inflammation: the role of VEGF
肉芽肿性炎症的先天免疫:VEGF 的作用
  • 批准号:
    9130425
  • 财政年份:
    2015
  • 资助金额:
    $ 40.69万
  • 项目类别:
Traffic from chronic mycobacterium induced granulomas
来自慢性分枝杆菌诱导的肉芽肿的交通
  • 批准号:
    7574403
  • 财政年份:
    2008
  • 资助金额:
    $ 40.69万
  • 项目类别:
Traffic from chronic mycobacterium induced granulomas
来自慢性分枝杆菌诱导的肉芽肿的交通
  • 批准号:
    7471830
  • 财政年份:
    2008
  • 资助金额:
    $ 40.69万
  • 项目类别:
BD LSR II BLUE LASER FLOW CYTOMETER: T CELLS IN GRANULOMATOUS IMMUNE RESPONSES
BD LSR II 蓝色激光流式细胞仪:肉芽肿免疫反应中的 T 细胞
  • 批准号:
    7335001
  • 财政年份:
    2006
  • 资助金额:
    $ 40.69万
  • 项目类别:
BD LSR II BLUE LASER FLOW CYTOMETER: TRYPANOSOMIASIS, PULMONARY HISTOPLASMOSIS
BD LSR II 蓝色激光流式细胞仪:锥虫病、肺组织胞浆菌病
  • 批准号:
    7335002
  • 财政年份:
    2006
  • 资助金额:
    $ 40.69万
  • 项目类别:
BD LSR II Blue Laser Flow cytometer
BD LSR II 蓝色激光流式细胞仪
  • 批准号:
    7040909
  • 财政年份:
    2006
  • 资助金额:
    $ 40.69万
  • 项目类别:
BD LSR II BLUE LASER FLOW CYTOMETER
BD LSR II 蓝色激光流式细胞仪
  • 批准号:
    7334998
  • 财政年份:
    2006
  • 资助金额:
    $ 40.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了